Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
cvUXvMTzNf6JSCqg
Listen
